Analyzing Zentek (NASDAQ:ZTEK) & N-able (NYSE:NABL)

N-able (NYSE:NABLGet Free Report) and Zentek (NASDAQ:ZTEKGet Free Report) are both small-cap business services companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, analyst recommendations, profitability and earnings.

Profitability

This table compares N-able and Zentek’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
N-able -1.31% 4.17% 2.41%
Zentek -914.51% -57.52% -44.73%

Analyst Ratings

This is a summary of current recommendations for N-able and Zentek, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
N-able 1 3 4 0 2.38
Zentek 1 0 0 0 1.00

N-able presently has a consensus target price of $9.45, suggesting a potential upside of 78.47%. Given N-able’s stronger consensus rating and higher probable upside, equities research analysts clearly believe N-able is more favorable than Zentek.

Insider & Institutional Ownership

96.4% of N-able shares are held by institutional investors. Comparatively, 0.8% of Zentek shares are held by institutional investors. 1.5% of N-able shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Volatility & Risk

N-able has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500. Comparatively, Zentek has a beta of 0.38, indicating that its share price is 62% less volatile than the S&P 500.

Earnings and Valuation

This table compares N-able and Zentek”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
N-able $466.15 million 2.12 $30.96 million ($0.03) -176.50
Zentek $1.22 million 57.51 -$7.22 million ($0.05) -13.05

N-able has higher revenue and earnings than Zentek. N-able is trading at a lower price-to-earnings ratio than Zentek, indicating that it is currently the more affordable of the two stocks.

Summary

N-able beats Zentek on 12 of the 14 factors compared between the two stocks.

About N-able

(Get Free Report)

N-able, Inc. provides cloud-based software solutions for managed service providers in the United States, the United Kingdom, and internationally. The company's solutions enable MSPs to support digital transformation and growth within small and medium-sized enterprises. It provides software platform designed to be an integrated, enterprise-grade solution that serves as an operating system for its MSP partners and scales as their businesses grow. In addition, the company offers remote monitoring and management solutions provide MSP partners with visibility and insights into the availability and performance of their customers' networks, infrastructure, devices and applications through a centralized dashboard; data protection as-a-service solutions, such as backup and disaster recovery for servers, virtual machines, workstations, files, data, and key cloud-based applications, as well as multi-tenant platform and secure remote delivery architecture. Further, it offers security services through patch management, endpoint security, managed detection and response, web protection, e-mail security, and archiving and vulnerability assessment solutions. Additionally, the company engages in professional services automation, automation and scripting management, password management policies and reporting, and analytics. N-able, Inc. was incorporated in 2020 and is headquartered in Burlington, Massachusetts.

About Zentek

(Get Free Report)

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Guelph, Canada.

Receive News & Ratings for N-able Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N-able and related companies with MarketBeat.com's FREE daily email newsletter.